Abstract
Regulation of iron metabolism is crucial: both iron deficiency and iron overload can cause disease. In recent years, our understanding of the syndromes of Neurodegeneration with Brain Iron Accumulation (NBIA) continues to grow considerably. These are characterized by excessive iron deposition in the brain, mainly the basal ganglia. Pantothenate kinase-associated neurodegeneration (PKAN, NBIA1) and PLA2G6-associated neurodegeneration (PLAN, NBIA2) are the core syndromes, but several other genetic causes have been identified (including FA2H, C19orf12, ATP13A2, CP and FTL). These conditions show a wide clinical and pathological spectrum, with clinical overlap between the different NBIA disorders and other diseases including spastic paraplegias, leukodystrophies, and neuronal ceroid lipofuscinosis. Lewy body pathology was confirmed in some clinical subtypes (C19orf12-associated neurodegeneration and PLAN). Research aims at disentangling the various NBIA genes and their related pathways to move towards pathogenesis-targeted therapies. Until then treatment remains symptomatic. Here we will introduce the group of NBIA syndromes and review the main clinical features and investigational findings.
Similar content being viewed by others
References
Aggarwal A, Schneider SA, Houlden H et al (2010) Indian-subcontinent NBIA: unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms. Mov Disord 25:1424–1431
Awasthi R, Gupta RK, Trivedi R et al (2010) Diffusion tensor MR imaging in children with pantothenate kinase-associated neurodegeneration with brain iron accumulation and their siblings. AJNR Am J Neuroradiol 31:442–447
Barbeito AG, Garringer HJ, Baraibar MA et al (2009) Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene. J Neurochem 109:1067–1078
Behrens MI, Bruggemann N, Chana P et al (2010) Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations. Mov Disord 25:1929–1937
Bras J, Singleton A, Cookson MR et al (2008) Potential role of ceramide metabolism in Lewy body disease. Eur J Biochem (FEBS) 275:5767–5773
Bras J, Verloes A, Schneider SA et al (2012) Mutation of the Parkinsonism Gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Hum Mol Genet 21(12):2646–2650
Bruggemann N, Hagenah J, Reetz K et al (2010) Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype. Arch Neurol 67:1357–1363
Brunetti D, Dusi S, Morbin M et al. (2012) Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model. Hum Mol Genet (epub ahead of print)
Campanella A, Privitera D, Guaraldo M et al (2012) Skin fibroblasts from pantothenate kinase-associated neurodegeneration patients show altered cellular oxidative status and have defective iron-handling properties. Hum Mol Genet 21:4049–4059
Carlier G, Dubru JM (1979) Familial juvenile Parkinsonism. Acta Psychiatr Belg 32:123–127
Castelnau P, Cif L, Valente EM et al (2005) Pallidal stimulation improves pantothenate kinase-associated neurodegeneration. Ann Neurol 57:738–741
Catoire H et al (2011) Restless legs syndrome-associated MEIS1 risk variant influences iron homeostasis. Ann Neurol 70:170–175
Chiapparini L, Savoiardo M, D’Arrigo S et al (2011) The “eye-of-the-tiger” sign may be absent in the early stages of classic pantothenate kinase associated neurodegeneration. Neuropediatrics. 42:159–162
Chien HF, Bonifati V, Barbosa ER (2011) ATP13A2-related neurodegeneration (PARK9) without evidence of brain iron accumulation. Mov Disord 26(7):1364–1365
Chinnery PF (1993) Neuroferritinopathy. In: Pagon RA, Bird TD, Dolan CR, Stephens K (eds) GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle, 1993–2005
Chinnery PF, Curtis AR, Fey C et al (2003) Neuroferritinopathy in a French family with late onset dominant dystonia. J Med Genet 40:e69
Chinnery PF, Crompton DE, Birchall D et al (2007) Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain 130:110–119
Dan P, Edvardson S, Bielawski J et al (2011) 2-Hydroxylated sphingomyelin profiles in cells from patients with mutated fatty acid 2-hydroxylase. Lipids Health Dis 10:84
De Volder AG, Cirelli S, de Barsy T et al (1990) Neuronal ceroid-lipofuscinosis: preferential metabolic alterations in thalamus and posterior association cortex demonstrated by PET. J Neurol Neurosurg Psychiatry 53:1063–1067
Dehay B, Martinez-Vicente M, Ramirez A et al (2012) Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove. Autophagy 8:1389–1391
Delgado RF, Sanchez PR, Speckter H et al (2011) Missense PANK2 mutation without “Eye of the tiger” sign: MR findings in a large group of patients with pantothenate kinase-associated neurodegeneration (PKAN). J Magn Reson Imaging 35(4):788–794
Deng X, Vidal R, Englander EW (2010) Accumulation of oxidative DNA damage in brain mitochondria in mouse model of hereditary ferritinopathy. Neurosci Lett 479:44–48
Deschauer M, Gaul C, Behrmann C et al (2012) C19orf12 mutations in neurodegeneration with brain iron accumulation mimicking juvenile amyotrophic lateral sclerosis. J Neurol 259(11):2434–2439
Devos D, Tchofo PJ, Vuillaume I et al (2009) Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation. Brain 132:e109
Dezortova M, Herynek V, Krssak M et al (2012) Two forms of iron as an intrinsic contrast agent in the basal ganglia of PKAN patients. Contrast Media Mol Imaging 7:509–515
Di Fonzo A, Chien HF, Socal M et al (2007) ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology. 68:1557–1562
Dick KJ, Eckhardt M, Paisan-Ruiz C et al (2010) Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35). Hum Mutat 31:E1251–E1260
Doi H, Koyano S, Miyatake S et al (2010) Siblings with the adult-onset slowly progressive type of pantothenate kinase-associated neurodegeneration and a novel mutation, Ile346Ser, in PANK2: clinical features and (99 m) Tc-ECD brain perfusion SPECT findings. J Neurol Sci 290:172–176
Dusek P, Jankovic J, Weidong L (2012) Iron dysregulation in movement disorders. Neurobiol Dis 46:1–18
Edvardson S, Hama H, Shaag A et al (2008) Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia. Am J Hum Genet 83:643–648
Eidelberg D, Sotrel A, Joachim C et al (1987) Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. A discrete clinicopathological entity. Brain 110(Pt 4):993–1013
Farias FH, Zeng R, Johnson GS et al (2011) A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers. Neurobiol Dis 42(3):468–474
Fermin-Delgado R, Roa-Sanchez P, Speckter H et al. (2012) Involvement of globus pallidus and midbrain nuclei in pantothenate kinase-associated neurodegeneration: measurement of T2 and T2* Time. Clin Neuroradiol (epub ahead of print)
Fleming RE, Ponka P (2012) Iron overload in human disease. N Engl J Med 366:348–359
Galvin JE, Giasson B, Hurtig HI et al (2000) Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology. Am J Pathol 157:361–368
Garone C, Pippucci T, Cordelli DM et al (2011a) FA2H-related disorders: a novel c.270 + 3A > T splice-site mutation leads to a complex neurodegenerative phenotype. Dev Med Child Neurol 53(10):958–961
Garone C, Pippucci T, Cordelli DM et al (2011b) FA2H-related disorders: a novel c.270 + 3A > T splice-site mutation leads to a complex neurodegenerative phenotype. Dev Med Child Neurol 53:958–961
Gonzalez-Cuyar LF, Perry G, Miyajima H et al (2008) Redox active iron accumulation in aceruloplasminemia. Neuropathology. 28:466–471
Grandas F, Fernandez-Carballal C, Guzman-de-Villoria J et al (2011) Treatment of a dystonic storm with pallidal stimulation in a patient with PANK2 mutation. Mov Disord 26:921–922
Gregory A, Hayflick S (2009) Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet 46(2):73–80
Gregory A, Westaway SK, Holm IE et al (2008) Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology 71:1402–1409
Gruenewald A, Arns B, Seibler P et al (2012) ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome. Neurobiol Aging 33(8):1843
Hajek M, Adamovicova M, Herynek V et al (2005) MR relaxometry and 1H MR spectroscopy for the determination of iron and metabolite concentrations in PKAN patients. Eur Radiol 15:1060–1068
Hartig MB, Hortnagel K, Garavaglia B et al (2006) Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Ann Neurol 59:248–256
Hartig MB, Iuso A, Haack T et al (2011) Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. Am J Hum Genet 89:543–550
Hautot D, Pankhurst QA, Morris CM et al (2006) Preliminary observation of elevated levels of nanocrystalline iron oxide in the basal ganglia of neuroferritinopathy patients. Biochim Biophys Acta 1772(1):21–25
Hayflick SJ (2006) Neurodegeneration with brain iron accumulation: from genes to pathogenesis. Semin Pediatr Neurol. 13:182–185
Hayflick SJ, Penzien JM, Michl W et al (2001) Cranial MRI changes may precede symptoms in Hallervorden-Spatz syndrome. Pediatr Neurol 25:166–169
Hayflick SJ, Westaway SK, Levinson B et al (2003) Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 348:33–40
Hayflick SJ, Hartman M, Coryell J et al (2006) Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. AJNR Am J Neuroradiol 27:1230–1233
Horvath R, Holinski-Feder E, Neeve V et al.(2012) A new phenotype of brain iron accumulation with dystonia, optic atrophy and peripheral neuropathy. Mov Disord (in press)
Kaneko K, Hineno A, Yoshida K et al (2012) Extensive brain pathology in a patient with aceruloplasminemia with a prolonged duration of illness. Hum Pathol 43:451–456
Keogh MJ, Jonas P, Coulthard A et al (2012) Neuroferritinopathy: a new inborn error of iron metabolism. Neurogenetics 13:93–96
Kostic VS, Svetel M, Mijajlovic M et al (2011) Transcranial sonography in pantothenate kinase-associated neurodegeneration. J Neurol 259(5):959–964
Kotzbauer PT, Truax AC, Trojanowski JQ et al (2005) Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2. J Neurosci 25:689–698
Krause M, Fogel W, Tronnier V et al (2006) Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration. Mov Disord 21:2255–2257
Kruer M, Gregory A, Hogarth P, Hayflick S (2009) Static encephalopathy of childhood with neurodegeneration in adulthood (SENDA syndrome): a novel neurodegneration with brain iron accumulation (NBIA) phenotype. (oral correspondence). Ref Type: Abstract
Kruer MC, Paisan-Ruiz C, Boddaert N et al (2010) Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol 68(5):611–618
Kruer MC, Hiken M, Gregory A et al (2011) Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration. Brain. 134:947–958
Kruer MC, Paudel R, Wagoner W et al (2012) Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts. Neurosci Lett 523:35–38
Kubota A, Hida A, Ichikawa Y et al (2008) A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: Description of clinical features and implications for genotype-phenotype correlations. Mov Disord 24(3):441–445
Kupsch A, Kuehn A, Klaffke S et al (2003) Deep brain stimulation in dystonia. J Neurol 250(Suppl 1):I47–I52
Kurian MA, Morgan NV, MacPherson L et al (2008) Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology 70:1623–1629
Levy M, Turtzo C, Llinas RH (2007) Superficial siderosis: a case report and review of the literature. Nat Clin Pract Neurol 3:54–58
Li X, Jankovic J (2011) Iron chelation and neuroprotection in neurodegenerative diseases. J Neural Transm 118:473–477
Liman J, Wellmer A, Rostasy K et al (2011) Transcranial ultrasound in neurodegeneration with brain iron accumulation (NBIA). Eur J Paediatr Neurol 16(2):175–178
Mak CM, Sheng B, Lee HH et al (2011) Young-onset parkinsonism in a Hong Kong Chinese man with adult-onset Hallervorden-Spatz syndrome. Int J Neurosci 121:224–227
Malik I, Turk J, Mancuso DJ et al (2008) Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations. Am J Pathol 172:406–416
Marelli C, Piacentini S, Garavaglia B et al (2005) Clinical and neuropsychological correlates in two brothers with pantothenate kinase-associated neurodegeneration. Mov Disord 20:208–212
McNeill A, Birchall D, Hayflick SJ et al (2008a) T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 70:1614–1619
McNeill A, Pandolfo M, Kuhn J et al (2008b) The neurological presentation of ceruloplasmin gene mutations. Eur Neurol 60:200–205
McNeill A, Birchall D, Hayflick SJ et al (2008c) T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology. 70:1614–1619
Mikati MA, Yehya A, Darwish H et al (2009) Deep brain stimulation as a mode of treatment of early onset pantothenate kinase-associated neurodegeneration. Eur J Paediatr Neurol 13:61–64
Morgan NV, Westaway SK, Morton JE et al (2006) PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 38:752–754
Najim al-Din AS, Wriekat A, Mubaidin A et al (1994) Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome. Acta Neurol Scand 89:347–352
Neumann M, Adler S, Schluter O et al (2000) Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies. Acta Neuropathol 100:568–574
Oide T, Yoshida K, Kaneko K et al (2006) Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia. Neuropathol Appl Neurobiol 32:170–176
Ondo WG, Adam OR, Jankovic J et al (2010) Dramatic response of facial stereotype/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States. Mov Disord 25:2470–2472
Ostrem JL, Marks WJ Jr, Volz MM et al (2007) Pallidal deep brain stimulation in patients with cranial-cervical dystonia (Meige syndrome). Mov Disord 22:1885–1891
Paisan-Ruiz C, Bhatia KP, Li A et al (2009) Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol 65:19–23
Paisan-Ruiz C, Li A, Schneider SA et al (2010a) Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging 33(4):814–823
Paisan-Ruiz C, Guevara R, Federoff M et al (2010b) Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord 25:1791–1800
Park JS, Mehta P, Cooper AA et al (2011) Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset Parkinsonism. Hum Mutat 32(8):956–964
Pierson TM, Simeonov DR, Sincan M et al (2012) Exome sequencing and SNP analysis detect novel compound heterozygosity in fatty acid hydroxylase-associated neurodegeneration. Eur J Hum Genet 20:476–479
Potter KA, Kern MJ, Fullbright G et al (2011) Central nervous system dysfunction in a mouse model of Fa2h deficiency. Glia 59:1009–1021
Ramirez A, Heimbach A, Grundemann J et al (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38:1184–1191
Saito Y, Kawai M, Inoue K et al (2000) Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course. J Neurol Sci 177:48–59
Schneider SA, Bhatia KP (2010) Three faces of the same gene: fA2H links neurodegeneration with brain iron accumulation, leukodystrophies, and hereditary spastic paraplegias. Ann Neurol 68:575–577
Schneider SA, Hardy J, Bhatia KP (2009) Iron accumulation in syndromes of neurodegeneration with brain accumulation—causative or consequential? J Neurol Neurosurg Psychiatry 80:589–590
Schneider SA, Paisan-Ruiz C, Quinn NP et al (2010) ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. Mov Disord 25:979–984
Schneider SA, Hardy J, Bhatia KP (2012) Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations. Mov Disord 27:42–53
Seo JH, Song SK, Lee PH (2009) A Novel PANK2 mutation in a patient with atypical pantothenate-kinase-associated neurodegeneration presenting with adult-onset Parkinsonism. J Clin Neurol 5:192–194
Speelman JD, Contarino MF, Schuurman PR et al (2010) Deep brain stimulation for dystonia: patient selection and outcomes. Eur J Neurol 17(Suppl 1):102–106
Stankiewicz J, Panter SS, Neema M et al (2007) Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics 4:371–386
Szumowski J, Bas E, Gaarder K et al (2010) Measurement of brain iron distribution in Hallevorden-Spatz syndrome. J Magn Reson Imaging 31:482–489
Thomas M, Hayflick SJ, Jankovic J (2004) Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Mov Disord 19:36–42
Timmermann L, Pauls KA, Wieland K et al (2010) Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation. Brain 133:701–712
Tome FM, Brunet P, Fardeau M et al (1985) Familial disorder of the central and peripheral nervous systems with particular cytoplasmic lamellated inclusions in peripheral nerves, muscle satellite cells, and blood capillaries. Acta Neuropathol 68:209–217
Tonelli A, D’Angelo MG, Arrigoni F et al (2012) Atypical adult onset complicated spastic paraparesis with thin corpus callosum in two patients carrying a novel FA2H mutation. Eur J Neurol 19(11):e127–e129
Usenovic M, Knight AL, Ray A et al (2012) Identification of novel ATP13A2 interactors and their role in alpha-synuclein misfolding and toxicity. Hum Mol Genet 21:3785–3794
Vidal R, Ghetti B, Takao M et al (2004) Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol 63:363–380
Vinters H, Farrell M, Mischel P et al. (1998) Diagnostic neuropathology. New York, NY, USA: Marcel Dekker Incorporated: 502
Wakabayashi K, Fukushima T, Koide R et al (2000) Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and lewy body pathology. Acta Neuropathol 99:331–336
Waldvogel D, van GP, Hallett M (1999) Increased iron in the dentate nucleus of patients with Friedrich’s ataxia. Ann Neurol 46:123–125
Williams DR, Hadeed A (2005) al Din AS et al. Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia. Mov Disord 20:1264–1271
Williamson K, Sima AA, Curry B et al (1982) Neuroaxonal dystrophy in young adults: a clinicopathological study of two unrelated cases. Ann Neurol 11:335–343
Wohlke A, Philipp U, Bock P et al (2011) A one base pair deletion in the canine ATP13A2 gene causes exon skipping and late-onset neuronal ceroid lipofuscinosis in the Tibetan terrier. PLoS Genet 7:e1002304
Yoshida K, Kaneko K, Miyajima H et al (2000) Increased lipid peroxidation in the brains of aceruloplasminemia patients. J Neurol Sci 175:91–95
Zhu W, Li X, Luo F et al (2010) Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration. Neurobiol Dis 37:307–313
Zoller I, Meixner M, Hartmann D et al (2008) Absence of 2-hydroxylated Sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration. J Neurosci 28:9741–9754
Acknowledgments
We are grateful to The Bosch Foundation.
Conflict of interest
The authors have no financial relationship with the organization that sponsored the research.
Author information
Authors and Affiliations
Corresponding author
Additional information
For the special issue “MDPD 2012” edited by Amos D. Korczyn and H. Reichmann.
Rights and permissions
About this article
Cite this article
Schneider, S.A., Bhatia, K.P. Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA). J Neural Transm 120, 695–703 (2013). https://doi.org/10.1007/s00702-012-0922-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-012-0922-8